Inflammation and coronary artery disease: As a new biomarker neutrophil/lymphocyte ratio;Enflamasyon ve koroner arter hastaliǧi: Yeni biyobelirteç olarak nötrofil/lenfosit orani

Turk Kardiyoloji Dernegi Arsivi

Volumn 41, Issue 3, 2013, Pages 191-192

  Kaya, Mehmet Güngör ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Coronary aneurysm; Coronary angiography; Coronary vessels pathology; Lymphocyte count; Neutrophils

Indexed keywords

CORONARY ARTERY DISEASE; EDITORIAL; HUMAN; INFLAMMATION; LYMPHOCYTE; NEUTROPHIL; BLOOD; CYTOLOGY; PATHOLOGY;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; LYMPHOCYTES; NEUTROPHILS;

EID: 84878211622     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2013.84484     Document Type: Editorial

References (10)

1. Gotto AM Jr. Role of C-reactive protein in coronary risk reduction: focus on primary prevention. Am J Cardiol 2007;99:718-25.
2. Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol 1996;78:945-8. (Pubitemid 126658660)
3. Kirtane AJ, Bui A, Murphy SA, Barron HV, Gibson CM. Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. Am J Cardiol 2004;93:532-6. (Pubitemid 38293053)
4. Thomson SP, Gibbons RJ, Smars PA, Suman VJ, Pierre RV, Santrach PJ, et al. Incremental value of the leukocyte differential and the rapid creatine kinase-MB isoenzyme for the early diagnosis of myocardial infarction. Ann Intern Med 1995;122:335-41.
5. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91.
6. Kalay N, Dogdu O, Koc F, Yarlioglues M, Ardic I, Akpek M, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology 2012;63:213-7.
7. Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012;110:621-7.
8. Kaya MG, Akpek M, Lam YY, Yarlioglues M, Celik T, Gunebakmaz O, et al. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study. Int J Cardiol 2012 Dec 5. (In press)
9. Turnan H, Erbay AR, Yasar AS, Balci M, Bicer A, Yetkin E. Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease. Am J Cardiol 2004;94:1303-6. (Pubitemid 39469956)
10. Ayhan SS, Öztürk S, Erdem A, Özlü MF, Özyaşar M, Erdem K, et al. Relation of neutrophil/lymphocyte ratio with the presence and severity of coronary artery ectasia. [Article in Turkish] Türk Kardiyol Dern Arş 2013;41:185-90.